What's happened to HSC?

[Alias123]

In May 2015, Histogen opened an $18M Series D financing round. This round will provide capital for development of its HSC program, including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, other corporate purposes and to support preparation for an initial public offering (IPO).

good news i guess!